Addex Therapeutics Ltd (ADXN)
Develops experimental drugs targeting brain and nerve disorders through molecular research.
$5.89+0.00%Healthcare
StockGlow Score
Bearish
BearishBullish
1 year ago-27.3%
The outlook
ADXN is trading near its 52-week lows, well below both its 50- and 200-day moving averages, reflecting a weak near-term trend. Current analyst coverage appears limited based on available data. Overall sentiment leans heavily bearish.
What’s behind the score
Price trendBelow its 50- & 200-day averages
52-week range7% of the way from its 52-week low to high
Market cap
$7.4M
52-wk high
$12.05
52-wk low
$5.41
50-day avg
$6.22
200-day avg
$7.33
Trailing P/E
—